Policy & Regulation
Fapon Biotech calls for cooperation of academic and industry partners for development of mucormycosis diagnostic tests
22 June 2021 -

Biotechnology development company Fapon Biotech Inc reported on Monday that Mucormycosis (black fungus) is a devastating infection that continues to rise in India during the COVID-19 pandemic, with more than 57,150 cases and a mortality of 54% in the country.

In addition to the high prevalence of diabetes in India, COVID-17 infected countries Pakistan, Russia, Nepal, Chile and Brazil, among others, have described the same problem and in areas with high rates of infection by diabetes and COVID-19 there should be alarm.

The company is calling for academic and industry partners in the development of mucormycosis diagnostic tests to share the capabilities of early stage raw material development platforms and reagent application platforms in the early stage. final phase.

Fapon Biotech supplies reagent raw materials for COVID-19 detection, with proven experience in helping partners to launch accredited reagents for COVID-19 in a short time.

Login
Username:

Password: